Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
29
|
pubmed:dateCreated |
1985-11-25
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0755-4982
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
7
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1560-1
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2932697-3-Iodobenzylguanidine,
pubmed-meshheading:2932697-Aged,
pubmed-meshheading:2932697-Carcinoma,
pubmed-meshheading:2932697-Humans,
pubmed-meshheading:2932697-Iodine Radioisotopes,
pubmed-meshheading:2932697-Iodobenzenes,
pubmed-meshheading:2932697-Male,
pubmed-meshheading:2932697-Thyroid Neoplasms
|
pubmed:year |
1985
|
pubmed:articleTitle |
[Medullary thyroid cancer may take up meta-iodobenzylguanidine].
|
pubmed:publicationType |
Letter,
Case Reports
|